Profound Medical Corp. Common Stock (PROF) Stock Price

PROFStock

$6.01+10.34%52W

Market Cap$219.56M

P/E—

PEG Ratio—

Div yield—

Beta2.29

PROF Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-9.55%

Price vs S&P 500 (4W)4.09%

VGM Score47.36

Book Value / Share (Quarterly)$1.36

P/TBV (Annual)3.19x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)34.06%

Cash Flow / Share (Quarterly)$-0.99

Price vs S&P 500 (YTD)-32.63%

Gross Margin (TTM)71.79%

Net Profit Margin (TTM)-171.57%

EPS (TTM)$-0.99

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-0.99

Revenue Growth (5Y)17.12%

EPS (Annual)$-1.41

ROI (Annual)-60.01%

Gross Margin (Annual)70.77%

Net Profit Margin (5Y Avg)-359.50%

Cash / Share (Quarterly)$1.05

Revenue Growth QoQ (YoY)12.30%

ROA (Last FY)-54.95%

Revenue Growth TTM (YoY)61.19%

EBITD / Share (TTM)$-1.05

ROE (5Y Avg)-58.99%

Operating Margin (TTM)-185.31%

Cash Flow / Share (Annual)$-1.06

P/B Ratio4.66x

P/B Ratio (Quarterly)4.87x

Net Income / Employee (Annual)$-325,000

EV / Revenue (TTM)10.39x

Net Interest Coverage (TTM)-38.77x

ROA (TTM)-51.24%

EPS Incl Extra (Annual)$-1.41

Current Ratio (Annual)12.52x

Quick Ratio (Quarterly)5.25x

3-Month Avg Trading Volume0.01M

52-Week Price Return10.34%

Revenue / Employee (TTM)$145,700

Tangible BV / Share (Quarterly)$1.36

P/S Ratio (Annual)14.41x

Asset Turnover (Annual)0.21x

52-Week High$12.40

Operating Margin (5Y Avg)-376.98%

EPS Excl Extra (Annual)$-1.41

CapEx CAGR (5Y)-7.11%

Tangible BV CAGR (5Y)-7.03%

26-Week Price Return0.35%

Quick Ratio (Annual)11.02x

13-Week Price Return-13.21%

Total Debt / Equity (Annual)0.07x

Current Ratio (Quarterly)6.46x

Enterprise Value$198.26M

Revenue / Share Growth (5Y)4.75%

Asset Turnover (TTM)0.30x

Book Value / Share Growth (5Y)-17.59%

Revenue / Employee (Annual)$122,900

Inventory Turnover (Annual)0.67x

Pretax Margin (Annual)-262.88%

Cash / Share (Annual)$1.65

3-Month Return Std Dev71.17%

Gross Margin (5Y Avg)57.14%

Net Income / Employee (TTM)$-250,000

ROE (Last FY)-64.08%

Net Interest Coverage (Annual)-8.13x

EPS Basic Excl Extra (Annual)$-1.41

Receivables Turnover (TTM)2.77x

Total Debt / Equity (Quarterly)0.09x

EPS Incl Extra (TTM)$-0.99

Receivables Turnover (Annual)2.36x

ROI (TTM)-58.01%

P/S Ratio (TTM)12.16x

Pretax Margin (5Y Avg)-358.38%

Revenue / Share (Annual)$0.53

Tangible BV / Share (Annual)$1.83

Price vs S&P 500 (52W)-5.20%

Year-to-Date Return-20.71%

5-Day Price Return-13.12%

EPS Normalized (Annual)$-1.41

ROA (5Y Avg)-47.90%

Net Profit Margin (Annual)-264.44%

Month-to-Date Return2.40%

Cash Flow / Share (TTM)$-1.82

EBITD / Share (Annual)$-1.35

Operating Margin (Annual)-256.27%

LT Debt / Equity (Annual)0.07x

ROI (5Y Avg)-52.16%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.99

P/TBV (Quarterly)4.88x

P/B Ratio (Annual)3.19x

Inventory Turnover (TTM)0.57x

Pretax Margin (TTM)-170.38%

Book Value / Share (Annual)$1.83

Price vs S&P 500 (13W)-15.90%

Beta2.29x

Revenue / Share (TTM)$0.53

ROE (TTM)-63.03%

52-Week Low$6.52

vGradeF

gGradeB

mGradeC

vgmGradeC

PROF Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.24	-$0.26	-7.22%(-$0.02)
Q1 2026	May 7, 2026	-$0.25	-$0.19	+25.20%(+$0.06)
Q4 2025	Mar 5, 2026	-$0.27	-$0.27	+1.22%(+$0.00)
Q3 2025	Nov 13, 2025	-$0.38	-$0.26	+30.85%(+$0.12)
Q2 2025	Aug 14, 2025	-$0.40	-$0.52	-30.82%(-$0.12)

PROF Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
PROFProfound Medical Corp. Common Stock	F	B	C	12.2x	17.1%	71.8%	-185.3%	$6.01
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Profound Medical Corp. Common Stock

Profound Medical develops minimally invasive, image-guided ablation systems for treating prostate disease. Its flagship TULSA-PRO system combines real-time MRI guidance with robotic ultrasound technology to precisely ablate prostate tissue without surgical incisions. The system integrates with hospitals' existing MRI infrastructure, requiring only disposable devices and durable equipment.

PROF Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.20

Revenue estimate$13.96M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

NAUTNautilus Biotechnolgy, Inc. Common StockLab Analytical Instruments
EYPTEyePoint, Inc. Common StockLab Analytical Instruments
QSIQuantum-Si Incorporated Class A Common StockMeasuring & Controlling Devices
ELMDElectromed, Inc.Electromedical Equipment
GPROGoPro, Inc.Photographic Equipment & Supplies
FOCLEDAP TMS S.A. American Depositary SharesElectromedical Equipment
RXSTRxSight, Inc. Common StockOphthalmic Goods
INGNInogen IncOrthopedic & Prosthetic Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.0

Buy

Consensus rating

Price Range (33 wk)

Low$5.06

High$8.36